Innate Pharma S.A. (LON:0EVI)
London
· Delayed Price · Currency is GBP · Price in EUR 1.500
-0.020 (-1.32%)
At close: Jul 11, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of 118.02 million as of July 14, 2025. Its market cap has decreased by -16.39% in one year.
Market Cap
118.02M
Enterprise Value
74.78M
Revenue
16.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 118.02M, an increase of 22,146.52%. That is a compound annual growth rate of 33.50%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.05B |
| HSBC Holdings | 158.20B |
| Shell | 157.53B |
| Unilever | 111.66B |
| British American Tobacco p.l.c. | 82.86B |
| Rolls-Royce Holdings | 82.44B |
| Rio Tinto Group | 75.96B |
| RELX PLC | 72.94B |